These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 15061569)

  • 21. Lipoxins: novel anti-inflammatory therapeutics?
    Godson C; Brady HR
    Curr Opin Investig Drugs; 2000 Nov; 1(3):380-5. PubMed ID: 11249723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
    Serhan CN
    Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoxins and new lipid mediators in the resolution of inflammation.
    Schwab JM; Serhan CN
    Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
    Romano M; Maddox JF; Serhan CN
    J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation?
    Bonnans C; Chanez P; Chavis C
    Allergy; 2004 Oct; 59(10):1027-41. PubMed ID: 15355460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoxins: putative braking signals in host defense, inflammation and hypersensitivity.
    Brady HR; Serhan CN
    Curr Opin Nephrol Hypertens; 1996 Jan; 5(1):20-7. PubMed ID: 8834158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs.
    Guilford WJ; Parkinson JF
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):245-50. PubMed ID: 15985364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
    Menezes-de-Lima O; Kassuya CA; Nascimento AF; Henriques Md; Calixto JB
    Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):123-35. PubMed ID: 16939877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of human neutrophil and endothelial cell ligand-operated extracellular acidification rate by microphysiometry: impact of reoxygenation.
    Gronert K; Colgan SP; Serhan CN
    J Pharmacol Exp Ther; 1998 Apr; 285(1):252-61. PubMed ID: 9536019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoxins: endogenous regulators of inflammation.
    McMahon B; Godson C
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F189-201. PubMed ID: 14707005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoxin receptors.
    Romano M; Recchia I; Recchiuti A
    ScientificWorldJournal; 2007 Sep; 7():1393-412. PubMed ID: 17767357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoxins: regulators of resolution.
    Ryan A; Godson C
    Curr Opin Pharmacol; 2010 Apr; 10(2):166-72. PubMed ID: 20226737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.
    Clària J; Lee MH; Serhan CN
    Mol Med; 1996 Sep; 2(5):583-96. PubMed ID: 8898374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential vascular roles for lipoxins in the "stop programs" of host defense and inflammation.
    Brady HR; Papayianni A; Serhan CN
    Trends Cardiovasc Med; 1995; 5(5):186-92. PubMed ID: 21232258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators.
    Serhan CN
    J Periodontol; 2008 Aug; 79(8 Suppl):1520-6. PubMed ID: 18673006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators.
    Chiang N; Serhan CN
    Methods Mol Biol; 2006; 341():227-50. PubMed ID: 16799203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of aspirin-triggered lipoxins in the mechanism of action of aspirin.
    Gilroy DW
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):203-10. PubMed ID: 15978791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis and lipoxins.
    Fierro IM
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):271-5. PubMed ID: 15982864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.
    Fierro IM; Serhan CN
    Braz J Med Biol Res; 2001 May; 34(5):555-66. PubMed ID: 11323741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution.
    Serhan CN
    Histochem Cell Biol; 2004 Oct; 122(4):305-21. PubMed ID: 15322859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.